Novartis AG Profile

85.95
USD 0.96  1.1%
29%
77%

Novartis AG Summary

Novartis AG (NVS) is traded on New York Stock Exchange in USA. It is located in SWITZERLAND and employs 121,597 people. Novartis AG is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 189.44 B. Novartis AG runs under Healthcare sector within Pharmaceutical Products industry. This company has 2.33 B outstanding shares of which 1.97 M shares are now shorted by investors with about 0.89 days to cover shorted positions. NOVARTIS AG ADS has about 9.45 B in cash with 9.75 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.08.
Check Novartis AG Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Novartis AG Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Novartis AG Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 16% 
Equity ratings for Novartis AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland. Novartis AG operates under Drug Manufacturers - Major classification in USA and traded on New York Stock Exchange exchange. It employs 121597 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameNovartis AG
CEOPaul HudsonAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationSWITZERLAND
Business AddressLichtstrasse 35
Foreign Associate  Argentina
ExchangeNew York Stock Exchange
CUSIP66987V109
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.novartis.com
Contact Number41 61 324 1111
Related EntityNVSEF
CurrencyUSD - US Dollar

Recommendations

Novartis AG Analyst Recommendations
Target PriceAdvice# of Analysts
92.0Buy4Odds
Novartis AG current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Novartis AG Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Novartis AG Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.15April 20, 2017
Novartis AG normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Novartis AG Corporate Directors
Ton Buechner Non-Executive Independent Director, MBA
Dimitri Azar Member of the Board of Directors, MBA
Frans Houten Non-Executive Independent Director